Edward Life Sciences (EW)

Wall Street's Best Investments Issue

You are trying to access subscriber-only content.

If you are a subscriber, log in here.

If you are not a subscriber, click here for your subscription. Subscribers will have unlimited access to our magazine articles and more!

Article Excerpt

This medical company beat estimates by five cents last quarter, seven analysts have recently raised their EPS estimates, and two have increased their price targets (JP Morgan to $98 and Credit Suisse to $88). Edward Life Sciences (EW) From Shortex Market Letter Edward Life Sciences (EW) 52 week high 83.44, 52 week low 61.38 Market […]

Comments